1. Home
  2. VYGR vs PROF Comparison

VYGR vs PROF Comparison

Compare VYGR & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$3.76

Market Cap

194.0M

Sector

Health Care

ML Signal

HOLD

Logo Profound Medical Corp.

PROF

Profound Medical Corp.

HOLD

Current Price

$5.46

Market Cap

270.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VYGR
PROF
Founded
2013
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
194.0M
270.7M
IPO Year
2015
2017

Fundamental Metrics

Financial Performance
Metric
VYGR
PROF
Price
$3.76
$5.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$21.00
$12.00
AVG Volume (30 Days)
837.1K
239.4K
Earning Date
03-09-2026
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
25.89
EPS
N/A
1.41
Revenue
$10,135,000.00
$16,098,000.00
Revenue This Year
$54.19
$115.41
Revenue Next Year
$20.22
$60.63
P/E Ratio
N/A
$3.87
Revenue Growth
N/A
50.73
52 Week Low
$2.65
$3.90
52 Week High
$5.55
$8.95

Technical Indicators

Market Signals
Indicator
VYGR
PROF
Relative Strength Index (RSI) 43.57 36.04
Support Level $3.60 $5.45
Resistance Level $4.43 $5.94
Average True Range (ATR) 0.33 0.56
MACD -0.03 -0.09
Stochastic Oscillator 4.37 19.48

Price Performance

Historical Comparison
VYGR
PROF

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About PROF Profound Medical Corp.

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Share on Social Networks: